These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8383403)

  • 1. The onset of alcuronium and tubocurarine: alone and in combination.
    Roberts SP; Pollard BJ
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):195-8. PubMed ID: 8383403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with alcuronium and tubocurarine accelerates the onset of neuromuscular block.
    Pollard BJ
    Br J Anaesth; 1989 Jul; 63(1):7-11. PubMed ID: 2765345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response of alcuronium and d-tubocurarine in infants, children and adolescents.
    Meretoja OA; Brown TC; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):449-51. PubMed ID: 2268007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation.
    Pollard BJ; Jones RM
    Br J Anaesth; 1983 Nov; 55(11):1127-31. PubMed ID: 6315037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of d-tubocurarine priming on an ED95 dose of vecuronium bromide.
    Miguel RV; Barlow IK; Dombrowski DL
    J Clin Anesth; 1994; 6(2):106-9. PubMed ID: 7911306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Train-of-four fade during onset and recovery of neuromuscular block: a study in non-anaesthetized subjects.
    Turner GA; Williams JD; Baker DJ
    Br J Anaesth; 1989 Mar; 62(3):279-86. PubMed ID: 2564783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium.
    Buzello W; Schluermann D; Pollmaecher T; Spillner G
    Anesthesiology; 1987 Jun; 66(6):842-6. PubMed ID: 2884901
    [No Abstract]   [Full Text] [Related]  

  • 9. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to nondepolarizing muscle relaxants in children with tumours.
    Brown TC; Gregory M; Bell B; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):460-5. PubMed ID: 2176439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing interactions between hexamethonium and tubocurarine, pancuronium or alcuronium at the neuromuscular junction.
    Pollard BJ; van der Spek AF
    Br J Anaesth; 1988 Oct; 61(4):419-24. PubMed ID: 2903757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretreatment with oral pyridostigmine on subsequent activity of alcuronium in non-anaesthetized subjects.
    Turner GA; Williams JD; Baker DJ
    Br J Anaesth; 1991 Mar; 66(3):365-9. PubMed ID: 1849730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of non-depolarizing muscle relaxants. Studies in rats (author's transl)].
    Plötz J; Weis KH; Decker R
    Anaesthesist; 1974 Apr; 23(4):197-201. PubMed ID: 4477695
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of pipecuronium neuromuscular blockade.
    Diefenbach C; Mellinghoff H; Buzello W
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):189-91. PubMed ID: 8383402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of neuromuscular transmission. The effect of succinylcholine chloride on phase II block, with special reference to the effect of a small amount of d-tubocurarine on preparalytic facilitation].
    Kuze S; Murakami S
    Masui; 1973 Mar; 22(3):208-17. PubMed ID: 4354482
    [No Abstract]   [Full Text] [Related]  

  • 17. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of small incremental doses of d-tubocurarine on neuromuscular transmission in anesthetized man.
    Heisterkamp DV; Skovsted P; Cohen PJ
    Anesthesiology; 1969 May; 30(5):500-5. PubMed ID: 4305093
    [No Abstract]   [Full Text] [Related]  

  • 19. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.
    Krieg N; Crul JF; Booij LH
    Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.